
The COVID-19 pandemic has amplified inequities that historically underrepresented populations have faced for decades in the U.S. health care setting.
Hispanic and Latino patients with peripheral artery disease underuse guideline-recommended CV medications such as antiplatelet and lipid-lowering therapies, researchers found.
Hispanic women with pre-diabetes randomly assigned to 14 weeks of intensive lifestyle intervention, including cooking demonstrations and group grocery store trips, saw a significant decrease in body weight, waist circumference and fasting insulin at 1 year vs. women assigned to usual care, according to recent findings.